Literature DB >> 7795978

A comparison of the effects of methotrexate and misonidazole on the germinal cells of the subependymal plate of the rat.

G M Morris1, J W Hopewell, A D Morris.   

Abstract

The cytotoxic effects of the drugs methotrexate (MTX) and misonidazole have been assessed in the rat brain by quantifying changes in the constituent cell populations of a glial cell progenitor layer, the subependymal plate (SEP). Three distinct cell types can be identified in the SEP on the basis of their nuclear morphology: cells with small dark (SD), small light (SL) or large light (LL) nuclei. The cells with SD nuclei may present pluripotential glial cell precursors. A reduction in the total nuclear density of the SEP, after the local ventricular administration of MTX, could be accounted for largely by a loss of cells with SD nuclei; to approximately 45% of control values 2 days after MTX followed by a full recovery in numbers by day 5. A further decline in the number of cells with SD nuclei occurred at 12 weeks after MTX administration. The pattern of changes in the cellularity of the SEP, after misonidazole administration, were similar to those observed after MTX treatment, although the magnitude of the response was reduced. It was concluded that both drugs, but MTX in particular, could have a potential additive effect on glial progenitor cells when used in combination with other forms of cancer therapy including radiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795978     DOI: 10.1259/0007-1285-68-808-406

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  6 in total

Review 1.  Neurological complications following treatment of children with brain tumors.

Authors:  Michelle Monje; Paul Graham Fisher
Journal:  J Pediatr Rehabil Med       Date:  2011

Review 2.  Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis.

Authors:  Michelle Monje; Jörg Dietrich
Journal:  Behav Brain Res       Date:  2011-05-23       Impact factor: 3.332

3.  Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment.

Authors:  Erin M Gibson; Surya Nagaraja; Alfonso Ocampo; Lydia T Tam; Lauren S Wood; Praveen N Pallegar; Jacob J Greene; Anna C Geraghty; Andrea K Goldstein; Lijun Ni; Pamelyn J Woo; Ben A Barres; Shane Liddelow; Hannes Vogel; Michelle Monje
Journal:  Cell       Date:  2018-12-06       Impact factor: 41.582

Review 4.  Microglia in Cancer Therapy-Related Cognitive Impairment.

Authors:  Erin M Gibson; Michelle Monje
Journal:  Trends Neurosci       Date:  2021-03-02       Impact factor: 16.978

5.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

Authors:  Joerg Dietrich; Ruolan Han; Yin Yang; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2006

Review 6.  An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.

Authors:  Ankit Das; Niraja Ranadive; Manas Kinra; Madhavan Nampoothiri; Devinder Arora; Jayesh Mudgal
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.